APRE vs REGN: Which Stock is Better?
Side-by-side comparison of Aprea Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026
APRE
Aprea Therapeutics Inc
$0.88
REGN
Regeneron Pharmaceuticals Inc
$733.78
Key Metrics Comparison
| Metric | APRE | REGN | Winner |
|---|---|---|---|
| Market Cap | $6.22M | $77.69B | REGN |
| P/E Ratio | N/A | 17.57 | REGN |
| EPS (TTM) | $N/A | $41.71 | REGN |
| Revenue Growth | -1.0% | 0.0% | REGN |
| Gross Margin | -1619.1% | 45.8% | REGN |
Analyze APRE
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APRE or REGN a better investment?
Comparing APRE and REGN: Aprea Therapeutics Inc has a market cap of $6.22M while Regeneron Pharmaceuticals Inc has $77.69B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APRE and REGN?
APRE (Aprea Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APRE or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APRE or REGN?
REGN has higher revenue growth at 0.0% vs -1.0% for APRE.
Which company is more profitable: APRE or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to -1619.1% for APRE.
Which is the larger company: APRE or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.69B compared to $6.22M for APRE.
Should I buy APRE or REGN in 2026?
Both APRE and REGN have investment merit. APRE trades at $0.88 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APRE and REGN stock?
Key differences: Market Cap ($6.22M vs $77.69B), P/E Ratio (N/A vs 17.6x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (-1619.1% vs 45.8%).